Nakagawa K - Search Results

1

Interleukin 6 is associated with cachexia in patients with prostate cancer.

Kuroda K, Nakashima J, Kanao K, Kikuchi E, Miyajima A, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Murai M. Kuroda K, et al. Among authors: nakagawa k. Urology. 2007 Jan;69(1):113-7. doi: 10.1016/j.urology.2006.09.039. Urology. 2007. PMID: 17270630

2

Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.

Kanao K, Mizuno R, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M. Kanao K, et al. Among authors: nakagawa k. J Urol. 2009 Feb;181(2):480-5; discussion 485. doi: 10.1016/j.juro.2008.10.017. Epub 2008 Dec 19. J Urol. 2009. PMID: 19100568

3

Discontinuance of bacille Calmette-Guérin instillation therapy for nonmuscle-invasive bladder cancer has negative effect on tumor recurrence.

Takeda T, Kikuchi E, Yuge K, Matsumoto K, Miyajima A, Nakagawa K, Oya M. Takeda T, et al. Among authors: nakagawa k. Urology. 2009 Jun;73(6):1318-22. doi: 10.1016/j.urology.2008.12.039. Epub 2009 Feb 20. Urology. 2009. PMID: 19232694

4

Are predictive models for cancer volume clinically useful in localized prostate cancer?

Ishida M, Nakashima J, Hashiguchi A, Mizuno R, Shinoda K, Kikuchi E, Miyajima A, Nakagawa K, Mukai M, Oya M. Ishida M, et al. Among authors: nakagawa k. Int J Urol. 2009 Dec;16(12):936-40. doi: 10.1111/j.1442-2042.2009.02399.x. Int J Urol. 2009. PMID: 19832923

5

Docetaxel in combination with prednisolone for hormone refractory prostate cancer.

Ide H, Kikuchi E, Kono H, Nagata H, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M. Ide H, et al. Among authors: nakagawa k. Jpn J Clin Oncol. 2010 Jan;40(1):79-84. doi: 10.1093/jjco/hyp126. Epub 2009 Oct 16. Jpn J Clin Oncol. 2010. PMID: 19837689

6

Extraperitoneal approach induces postoperative inguinal hernia compared with transperitoneal approach after laparoscopic radical prostatectomy.

Yoshimine S, Miyajima A, Nakagawa K, Ide H, Kikuchi E, Oya M. Yoshimine S, et al. Among authors: nakagawa k. Jpn J Clin Oncol. 2010 Apr;40(4):349-52. doi: 10.1093/jjco/hyp172. Epub 2009 Dec 22. Jpn J Clin Oncol. 2010. PMID: 20031961

7

Late recurrence and progression in non-muscle-invasive bladder cancers after 5-year tumor-free periods.

Matsumoto K, Kikuchi E, Horiguchi Y, Tanaka N, Miyajima A, Nakagawa K, Nakashima J, Oya M. Matsumoto K, et al. Among authors: nakagawa k. Urology. 2010 Jun;75(6):1385-90. doi: 10.1016/j.urology.2009.09.088. Epub 2010 Jan 29. Urology. 2010. PMID: 20110108

8

Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines.

Kodaira K, Kikuchi E, Kosugi M, Horiguchi Y, Matsumoto K, Kanai K, Suzuki E, Miyajima A, Nakagawa K, Tachibana M, Umezawa K, Oya M. Kodaira K, et al. Among authors: nakagawa k. Urology. 2010 Apr;75(4):805-12. doi: 10.1016/j.urology.2009.11.048. Epub 2010 Feb 13. Urology. 2010. PMID: 20156648

9

The clinical significance of urine cytology after a radical cystectomy for urothelial cancer.

Yoshimine S, Kikuchi E, Matsumoto K, Ide H, Miyajima A, Nakagawa K, Oya M. Yoshimine S, et al. Among authors: nakagawa k. Int J Urol. 2010 Jun;17(6):527-32. doi: 10.1111/j.1442-2042.2010.02516.x. Epub 2010 Apr 1. Int J Urol. 2010. PMID: 20370849

10

Frequency of tumor recurrence: a strong predictor of stage progression in initially diagnosed nonmuscle invasive bladder cancer.

Tanaka N, Kikuchi E, Matsumoto K, Miyajima A, Nakagawa K, Oya M. Tanaka N, et al. Among authors: nakagawa k. J Urol. 2011 Feb;185(2):450-5. doi: 10.1016/j.juro.2010.09.087. Epub 2010 Dec 17. J Urol. 2011. PMID: 21167533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,817 results

Search Page

Filters